#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2114876	F	PubChem BioAssay. Late stage assay provider results from the probe development effort to identify inhibitors of diacylglycerol lipase, beta (DAGLb): LCMS-based biochemical dose response assay. (Class of assay: confirmatory)	Mus musculus	2	ALA1201862	assay format	PubChem BioAssays
2.	ALA2114878	F	PubChem BioAssay. Late stage assay provider results from the probe development effort to identify inhibitors of diacylglycerol lipase, beta (DAGLb): fluorescence-based dose-response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of DAGLb in vitro. (Class of assay: confirmatory)	Mus musculus	4	ALA1201862	assay format	PubChem BioAssays
3.	ALA2114935	F	PubChem BioAssay. Late stage assay provider results from the probe development effort to identify inhibitors of diacylglycerol lipase, beta (DAGLb): fluorescence-based dose-response biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition of antitarget ABHD6 in vitro, set 2. (Class of assay: confirmatory)	Mus musculus	1	ALA1201862	assay format	PubChem BioAssays
4.	ALA3268198	B	Inhibition of FP-rhodamine-labelled recombinant mouse DAGLbeta expressed in HEK293T cells at 100 nM preincubated for 30 mins followed by FP-rhodamine labelling measured after 30 mins by gel-based competitive ABPP assay	Mus musculus	5	ALA3259629	cell-based format	Scientific Literature
5.	ALA3268595	B	Inhibition of FP-rhodamine-labelled recombinant mouse DAGLbeta expressed in HEK293T cells at 10 uM preincubated for 30 mins followed by FP-rhodamine labelling measured after 30 mins by gel-based competitive ABPP assay	Mus musculus	5	ALA3259629	cell-based format	Scientific Literature
6.	ALA3268596	B	Inhibition of ABHD6 in FP-rhodamine-labelled mouse brain membrane at 10 nM preincubated for 30 mins followed by FP-rhodamine labelling measured after 30 mins by gel-based competitive ABPP assay	Mus musculus	14	ALA3259629	tissue-based format	Scientific Literature
7.	ALA3268598	B	Inhibition of mouse brain MGLL at 10 uM after 30 mins by FP-rhodamine ABPP-based mass spectrometry relative to control	Mus musculus	2	ALA3259629	assay format	Scientific Literature
8.	ALA3268603	B	Inhibition of ABHD6 in FP-rhodamine-labelled mouse brain membrane at 0.01 uM after 30 mins preincubated for 30 mins followed by HT-01 labelling measured after 30 mins by gel-based competitive ABPP assay	Mus musculus	5	ALA3259629	tissue-based format	Scientific Literature
9.	ALA3268604	B	Inhibition of MGLL in FP-rhodamine-labelled mouse brain membrane at 10 uM after 30 mins preincubated for 30 mins followed by HT-01 labelling measured after 30 mins by gel-based competitive ABPP assay	Mus musculus	5	ALA3259629	tissue-based format	Scientific Literature
10.	ALA4427013	B	Inhibition mouse DAGLbeta expressed in HEK293T cell membrane fractions using DAG as substrate preincubated for 30 mins followed by ABP HT01 probe addition measured after 30 mins in presence of probe by gel-based ABPP competition assay	Mus musculus	5	ALA4425142	cell-based format	Scientific Literature
11.	ALA4427014	B	Inhibition human DAGLalpha expressed in HEK293T cell membrane fractions using DAG as substrate preincubated for 30 mins followed by ABP HT01 probe addition measured after 30 mins in presence of probe by gel-based ABPP competition assay	Homo sapiens	5	ALA4425142	cell-based format	Scientific Literature
12.	ALA4427015	B	Inhibition of V-tagged mouse DAGLbeta expressed in HEK2934T cell membrane fractions using SAG as substrate assessed as accumulation of 2-AG preincubated for 30 mins followed by probe addition measured after 30 mins by LC-MS natural substrate assay	Mus musculus	2	ALA4425142	cell-based format	Scientific Literature